Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03374839 |
Title | Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients (Nivo-TIL) |
Acronym | Nivo-TIL |
Recruitment | Unknown status |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Nantes University Hospital |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | FRA |